(Q43770733)

26 November 2017

title

Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen (English)

1 reference

26 November 2017

0 references

0 references

1 reference

Jugminder S Chawla

1

1 reference

26 November 2017

Mansoor M Amiji

series ordinal

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

International Journal of Pharmaceutics

26 November 2017

published in

1 reference

26 November 2017

volume

249

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

127-138

1 reference

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Fighting cancer by attacking its blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

On the importance and mechanisms of burst release in matrix-controlled drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Barriers to drug delivery in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

1 reference

7 January 2021

Targeted Antiestrogens to Prevent Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Adjuvant therapy for resectable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Mechanisms of tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

A novel route to poly(epsilon-caprolactone)-based copolymers via anionic derivatization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900483-0

7 January 2021

10.1016/S0378-5173(02)00483-0

Identifiers

DOI

1 reference

26 November 2017

1 reference